Skip to content

Study · Animal study (in vivo) · mouse · 1983

3 results

[Morphofunctional state of organs of immunogenesis and adrenal glands after administration of a thymus preparation (thymaline)].

Khmel'nitskiĭ OK, Belianin VL, Grintsevich II, Katsers AR, Morozov VG

Arkhiv patologii1 Jan 1983

PMID6190469 (opens in a new tab)PepBankPUB-06190469
Publisher pageAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In normal CBA mice, thymaline enhanced thymus functioning after subcutaneous administration.

    In plain wordsIn normal mice, thymaline increased thymus function.

    Peptide
    Thymalin
    Outcome
    IncreaseThymus functioning
    Study

    mousen: not reported in source

    Normal CBA mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated · subcutaneous · 10-dayAs given in this study (mouse).

    Source sentences

    Summary
    Comparative characterization of morphofunctional changes in the thymus, secondary immunogenesis organs, and adrenal cortex after 10-day subcutaneous inoculations of CBA mice with a thymus preparation, thymaline, showed enhanced thymus functioning
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In normal CBA mice, thymaline administration produced not very marked signs of lymphocyte migrational activity in lymph nodes.

    In plain wordsIn normal mice, thymaline produced signs of lymphocyte movement in lymph nodes that were not very marked.

    Peptide
    Thymalin
    Outcome
    Not applicableLymphocyte migrational activity in lymph nodes
    Study

    mousen: not reported in source

    Normal CBA mice
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated · subcutaneous · 10-dayAs given in this study (mouse).

    Source sentences

    Summary
    showed enhanced thymus functioning and not very marked signs of migrational activity of lymphocytes in lymph nodes
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In normal CBA mice, prolonged thymaline exposure coincided with reduced hormonal activity of adrenocorticocytes.

    In plain wordsIn normal mice, prolonged thymaline exposure coincided with reduced hormone activity in adrenal cortex cells.

    Peptide
    Thymalin
    Outcome
    DecreaseAdrenocorticocyte hormonal activity
    Study

    mousen: not reported in source

    Normal CBA mice
    Outcome group
    Stress hormones · Endocrine and hormones
    Studied dose
    Dose not stated · subcutaneous · 10-dayAs given in this study (mouse).

    Source sentences

    Summary
    under conditions of a prolonged effect of thymaline in normal animals to run in a reduced hormonal activity of adrenocorticocytes.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.